loadpatents
name:-0.011610984802246
name:-0.026257038116455
name:-0.0015358924865723
KUMAR; Virendra Patent Filings

KUMAR; Virendra

Patent Applications and Registrations

Patent applications and USPTO patent grants for KUMAR; Virendra.The latest application filed is for "authenticating plaintext and ciphertext in a vehicle-to-everything (v2x) message".

Company Profile
1.37.13
  • KUMAR; Virendra - Sudbury MA
  • Kumar; Virendra - Watertown MA
  • Kumar; Virendra - Decatur GA US
  • Kumar; Virendra - Atlanta GA US
  • Kumar; Virendra - Berwyn PA
  • Kumar; Virendra - Paoli PA
  • Kumar; Virendra - Colonie NY
  • Kumar; Virendra - Tredyffrin Township Chester County
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Authenticating Plaintext And Ciphertext In A Vehicle-To-Everything (V2X) Message
App 20220295274 - WHYTE; William ;   et al.
2022-09-15
Method and System for Protecting Proprietary Information Used to Determine a Misbehavior Condition for Vehicle-to-Everything (V2X) Reporting
App 20220256333 - WHYTE; William ;   et al.
2022-08-11
Method and system for secure connected vehicle communication
Grant 11,018,875 - Chen , et al. May 25, 2
2021-05-25
Connected Vehicle Communication Wth Improved Misbehavior Processing
App 20190245705 - Kumar; Virendra ;   et al.
2019-08-08
Leakage resilient garbled circuit generation using reduced memory hardware token
Grant 9,401,804 - Kolesnikov , et al. July 26, 2
2016-07-26
Garbled circuit generation in a leakage-resilient manner
Grant 8,881,295 - Kolesnikov , et al. November 4, 2
2014-11-04
Provably secure and efficient pseudorandom number generation
Grant 8,824,677 - Ramzan , et al. September 2, 2
2014-09-02
Garbled Circuit Generation in a Leakage-Resilient Manner
App 20120079602 - Kolesnikov; Vladimir ;   et al.
2012-03-29
Leakage-Resilient Garbled Circuit Generation Using Reduced Memory Hardware Token
App 20120076302 - Kolesnikov; Vladimir ;   et al.
2012-03-29
Solid dispersions of opioid antagonists
Grant 7,914,776 - Kumar March 29, 2
2011-03-29
Kappa agonist compounds and pharmaceutical formulations thereof
Grant 7,294,647 - Kruse , et al. November 13, 2
2007-11-13
Solid dispersions of opioid antagonists
App 20070082053 - Kumar; Virendra
2007-04-12
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
Grant 6,960,612 - Kruse , et al. November 1, 2
2005-11-01
Kappa agonist compounds and pharmaceutical formulations thereof
App 20050020576 - Zhang, Wei Yuan ;   et al.
2005-01-27
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
App 20040220112 - Kruse, Lawrence I. ;   et al.
2004-11-04
Kappa agonist compounds and pharmaceutical formulations thereof
Grant 6,750,216 - Kumar , et al. June 15, 2
2004-06-15
Kappa agonist compounds and pharmaceutical formulations thereof
App 20030236248 - Kruse, Lawrence I. ;   et al.
2003-12-25
Kappa agonist compounds and pharmaceutical formulations thereof
App 20030144272 - Kumar, Virendra ;   et al.
2003-07-31
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
Grant 6,486,165 - Zhang , et al. November 26, 2
2002-11-26
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
Grant 6,476,063 - Zhang , et al. November 5, 2
2002-11-05
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
App 20020103164 - Zhang, Wei Yuan ;   et al.
2002-08-01
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
App 20020042399 - Kruse, Lawrence I. ;   et al.
2002-04-11
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
App 20020013296 - Zhang, Wei Yuan ;   et al.
2002-01-31
Kappa agonist compounds and pharmaceutical formulations thereof
Grant 6,303,611 - Zhang , et al. October 16, 2
2001-10-16
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
Grant 6,180,623 - Kruse , et al. January 30, 2
2001-01-30
Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
Grant 6,156,769 - Farrar , et al. December 5, 2
2000-12-05
Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
Grant 6,057,323 - Zhang , et al. May 2, 2
2000-05-02
Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritis therewith
Grant 6,054,445 - Zhang , et al. April 25, 2
2000-04-25
Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
Grant 6,048,860 - Farrar , et al. April 11, 2
2000-04-11
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
Grant 6,028,063 - Kruse , et al. February 22, 2
2000-02-22
Substituted N-arylmethyl and heterocylylmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
Grant 6,008,226 - Kumar , et al. December 28, 1
1999-12-28
Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith
Grant 5,981,513 - Kruse , et al. November 9, 1
1999-11-09
Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith
Grant 5,888,494 - Farrar , et al. March 30, 1
1999-03-30
2-Saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
Grant 5,856,349 - Dunlap , et al. January 5, 1
1999-01-05
Kappa agonist compounds pharmaceutical formulations and method of prevention and treatment of pruritus therewith
Grant 5,763,445 - Kruse , et al. June 9, 1
1998-06-09
Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith
Grant 5,760,023 - Farrar , et al. June 2, 1
1998-06-02
Kappa agonist compounds and pharmaceutical formulations thereof
Grant 5,744,458 - Kruse , et al. April 28, 1
1998-04-28
Kappa agonist compounds and pharmaceutical formulations thereof
Grant 5,688,955 - Kruse , et al. November 18, 1
1997-11-18
Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic conditions therewith
Grant 5,667,773 - Farrar , et al. September 16, 1
1997-09-16
Kappa agonist compounds and pharmaceutical formulations thereof
Grant 5,646,151 - Kruse , et al. July 8, 1
1997-07-08
Substituted N-arylmethyl and heterocyclmethyl-1H-pyrazolo[3,4-b]quinolin-4-amines and compositions and methods of use thereof
Grant 5,614,530 - Kumar , et al. March 25, 1
1997-03-25
Substituted heterocyclylisoquinolinium salts and compositions and method of use thereof
Grant 5,569,655 - Dority, Jr. , et al. October 29, 1
1996-10-29
Substituted N-cycloalkylmethyl-1H-pyrazolo(3,4-b)quinolin-4 amines and compositions and methods of use thereof
Grant 5,488,055 - Kumar , et al. January 30, 1
1996-01-30
2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
Grant 5,488,062 - Dunlap , et al. January 30, 1
1996-01-30
Morpholinoalkylindenes as antiglaucoma agents
Grant 5,292,736 - Kumar , et al. March 8, 1
1994-03-08
2-saccharinylmethyl aryl carboxylate
Grant 5,250,696 - Dunlap , et al. October 5, 1
1993-10-05
3-arylcarbonyl-1-(C-attached-N-heteryl)-1H-indoles
Grant 5,068,234 - D'Ambra , et al. November 26, 1
1991-11-26
Company Registrations
SEC0001516619Kumar Virendra

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed